Retracted: Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Autism spectrum disorder ( ASD ) is a frequent developmental disorder characterized by pervasive deficits in social interaction, impairment in verbal and nonverbal communication, and stereotyped patterns of interests and activities. It has been previously reported that there is vitamin D deficiency in autistic children; however, there is a lack of randomized controlled trials of vitamin D supplementation in ASD children. Methods: This study is a double‐blinded, randomized clinical trial ( RCT ) that was conducted on 109 children with ASD (85 boys and 24 girls; aged 3–10 years). The aim of this study was to assess the effects of vitamin D supplementation on the core symptoms of autism in children. ASD patients were randomized to receive vitamin D3 or placebo for 4 months. The serum levels of 25‐hydroxycholecalciferol (25 ( OH )D) were measured at the beginning and at the end of the study. The autism severity and social maturity of the children were assessed by the Childhood Autism Rating Scale ( CARS ), Aberrant Behavior Checklist ( ABC ), Social Responsiveness Scale ( SRS ), and the Autism Treatment Evaluation Checklist ( ATEC ). Trial registration number: UMIN ‐ CTR Study Design : trial number : UMIN 000020281. Results: Supplementation of vitamin D was well tolerated by the ASD children. The daily doses used in the therapy group was 300 IU vitamin D3/kg/day, not to exceed 5,000 IU /day. The autism symptoms of the children improved significantly, following 4‐month vitamin D3 supplementation, but not in the placebo group. This study demonstrates the efficacy and tolerability of high doses of vitamin D3 in children with ASD . Conclusions: This study is the first double‐blinded RCT proving the efficacy of vitamin D3 in ASD patients. Depending on the parameters measured in the study, oral vitamin D supplementation may safely improve signs and symptoms of ASD and could be recommended for children with ASD . At this stage, this study is a single RCT with a small number of patients, and a great deal of additional wide‐scale studies are needed to critically validate the efficacy of vitamin D in ASD .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940 · cited 1×
“Research has also shown that ASD children have lower plasma concentrations of oxytocin as compared with nonautistic children (Ashwood et al., 2011).”
ResultNew clues about vitamin D functions in the nervous system
Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00547-1 · Cited by 904
Guastella, A. J., Gray, K. M., Rinehart, N. J., Alvares, G. A., Tonge, B. J., Hickie, I. B., Keating, C. M., Cacciotti‐Saija, C., & Einfeld, S. L. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12305 · Cited by 299 · cited 1×
“Positive therapeutic results of oxytocin have been reported in ASD patients, including improved retention of speech comprehension and enhanced mindreading performance, social communication, and interaction (Aoki et al., 2015; Guastella et al., 2015).”
BackgroundSaad, K., Abdel-rahman, A. A., Elserogy, Y. M., Al-Atram, A. A., Cannell, J. J., Bjørklund, G., Abdel-Reheim, M. K., Othman, H. A. K., El-Houfey, A. A., Abd El-Aziz, N. H. R., et al. (2016) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000019 · Cited by 244
Self-citationCore Symptoms of Autism Improved After Vitamin D Supplementation
Jia, F., Wang, B., Shan, L., Xu, Z., Staal, W. G., & Du, L. (2015) · Pediatrics · doi:10.1542/peds.2014-2121 · Cited by 145 · cited 2×
“In a recent case report, a 32-month-old Chinese toddler with severe ASD was tested before and after vitamin D treatment (Jia et al., 2015).”
BackgroundSelf-citationClinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder
Feng, J., Shan, L., Du, L., Wang, B., Li, H., Wang, W., Wang, T., Dong, H., Yue, X., Xu, Z., et al. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1123847 · Cited by 141
Self-citationMaternal vitamin D levels and the autism phenotype among offspring
Whitehouse, A. J. O., Holt, B. J., Serralha, M., Holt, P. G., Hart, P. H., & Kusel, M. M. H. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1676-8 · Cited by 100
Aoki, Y., Watanabe, T., Abe, O., Kuwabara, H., Yahata, N., Takano, Y., Iwashiro, N., Natsubori, T., Takao, H., Kawakubo, Y., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.74 · Cited by 95 · cited 1×
“Positive therapeutic results of oxytocin have been reported in ASD patients, including improved retention of speech comprehension and enhanced mindreading performance, social communication, and interaction (Aoki et al., 2015; Guastella et al., 2015).”
BackgroundAutism prevalence in the united states with respect to solar UV-B doses: An ecological study
Grant, W. B., & Cannell, J. J. (2013) · Dermato-Endocrinology · doi:10.4161/derm.22942 · Cited by 67
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
Kang, D.-W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42183-0 · Cited by 749
Adams, J., Audhya, T., Geis, E., Gehn, E., Fimbres, V., Pollard, E., Mitchell, J., Ingram, J., Hellmers, R., Laake, D., et al. (2018) · Nutrients · doi:10.3390/nu10030369 · Cited by 267
“For future studies we recommend increasing the level of vitamin D, since the current supplement did not increase levels significantly despite supplementation levels well above the Recommended Dietary Allowance (RDA) for vitamin D, and other studies of even higher doses of vitamin D for ASD reported significant benefit…”
BackgroundAn update on pharmacotherapy for autism spectrum disorder in children and adolescents
Ji, N. Y., & Findling, R. L. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000132 · Cited by 217
Mazahery, H., Conlon, C. A., Beck, K. L., Mugridge, O., Kruger, M. C., Stonehouse, W., Camargo, C. A., Meyer, B. J., Jones, B., & von Hurst, P. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.017 · Cited by 106
Metadata
- Authors
- Saad, K., Abdel‐Rahman, A. A., Elserogy, Y. M., Al‐Atram, A. A., El‐Houfey, A. A., Othman, H. A. K., Bjørklund, G., Jia, F., Urbina, M. A., Abo‐Elela, M. G. M., Ahmad, F., Abd El‐Baseer, K. A., Ahmed, A. E., & Abdel‐Salam, A. M.
- Venue
- Journal of Child Psychology and Psychiatry
- Publisher
- Wiley
- Published
- 2016-11-21
- Volume
- 59
- Issue
- 1
- Pages
- 20-29
- ISSN
- 0021-9630 (ISSN-L)
- 1469-7610
- OpenAlex
- W2555743000
- Cited by
- 99
- References
- 9
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.